Park West Asset Management LLC Has $1.23 Million Stock Holdings in LENSAR, Inc. $LNSR

Key Points

• Park West Asset Management LLC reduced its stake in LENSAR, Inc. by 89.3%, selling 723,613 shares and holding only 87,063 shares, representing about 0.74% of the company.
• LENSAR's stock had a negative earnings per share (EPS) of ($0.15) for the last quarter, missing estimates by ($0.07), with revenue reported at $11.36 million compared to expectations of $16.55 million.
• The company's stock trades at $12.17, with a market cap of $145.31 million and a one-year price range of $3.80 to $17.31.

Park West Asset Management LLC reduced its holdings in LENSAR, Inc. (NASDAQ:LNSR - Free Report) by 89.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 87,063 shares of the company's stock after selling 723,613 shares during the quarter. Park West Asset Management LLC owned 0.74% of LENSAR worth $1,229,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. PenderFund Capital Management Ltd. acquired a new position in shares of LENSAR in the 1st quarter valued at approximately $236,000. Cubist Systematic Strategies LLC acquired a new position in LENSAR in the 1st quarter worth $369,000. OMERS ADMINISTRATION Corp bought a new position in LENSAR during the 1st quarter worth about $1,680,000. Gabelli Funds LLC acquired a new stake in shares of LENSAR in the 1st quarter valued at about $191,000. Finally, Groupe la Francaise acquired a new stake in shares of LENSAR in the 1st quarter valued at about $1,779,000. Institutional investors own 40.15% of the company's stock.

LENSAR Stock Down 0.6%

Shares of LNSR stock traded down $0.07 on Wednesday, hitting $12.13. 79,749 shares of the stock were exchanged, compared to its average volume of 60,506. LENSAR, Inc. has a fifty-two week low of $3.80 and a fifty-two week high of $17.31. The business has a 50-day moving average of $12.79 and a 200 day moving average of $13.30.

LENSAR (NASDAQ:LNSR - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.07). The firm had revenue of $11.36 million during the quarter, compared to the consensus estimate of $16.55 million. LENSAR had a negative net margin of 84.49% and a negative return on equity of 737.30%.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.